Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
Incyte Corporation
Merck Sharp & Dohme LLC
Stanford University
Emory University
Presage Biosciences
Bristol-Myers Squibb
Canadian Cancer Trials Group
University of Chicago
Eastern Cooperative Oncology Group
Tessa Therapeutics
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
University of California, Davis
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
Eli Lilly and Company
University of Maryland, Baltimore
Memorial Sloan Kettering Cancer Center
European Organisation for Research and Treatment of Cancer - EORTC
Trans Tasman Radiation Oncology Group
Genentech, Inc.
University of Maryland, Baltimore
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
University of Michigan Rogel Cancer Center
GERCOR - Multidisciplinary Oncology Cooperative Group
Emory University
University of Alabama at Birmingham
SWOG Cancer Research Network
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
SCRI Development Innovations, LLC
National Cancer Institute (NCI)